Back
Aptevo Therapeutics Stock Price Chart
Sponsored
APVO
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
APVO
Aptevo Therapeutics
Last Price:
9.02
Seasonality Move:
-25.1%
7 Day Trial
ALL ACCESS PASS
$
7
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APVO is experiencing slight selling pressure.
Aptevo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.35 | Buy |
20-day SMA: | 0.69 | Buy |
50-day SMA: | 0.4 | Buy |
200-day SMA: | 1.33 | Buy |
8-day EMA: | 2.15 | Buy |
20-day EMA: | 1.08 | Buy |
50-day EMA: | 0.61 | Buy |
200-day EMA: | 5.26 | Buy |
Aptevo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.68 | Buy |
Relative Strength Index (14 RSI): | 45.25 | Sell |
Chaikin Money Flow: | -17908 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-1.04 - 2.26) | Buy |
Bollinger Bands (100): | (-0.46 - 1.22) | Buy |
Aptevo Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 8.70 while APVO 8-day simple moving average is 1.35, which is a Buy signal.
- The stock price of APVO is 8.70 while Aptevo Therapeutics 20-day SMA is 0.69, which makes it a Buy.
- Aptevo Therapeutics 50-day simple moving average is 0.40 while APVO share price is 8.70, making it a Buy technically.
- APVO stock price is 8.70 and Aptevo Therapeutics 200-day simple moving average is 1.33, creating a Buy signal.
APVO Technical Analysis vs Fundamental Analysis
Buy
51
Aptevo Therapeutics (APVO)
is a Buy
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a Buy
The current Aptevo Therapeutics [APVO] share price is $8.70. The Score for APVO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
4.35M
Price in USD:
8.70
Share Volume:
45.46K
Aptevo Therapeutics 52-Week Range
52-Week High:
399.60
52-Week Low:
5.11
Buy
51
Aptevo Therapeutics (APVO)
is a Buy
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?
The Aptevo Therapeutics stock price is 8.70 USD today. -
Will APVO stock go up or go down?
Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aptevo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is not overvalued.
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 8.70 while APVO 8-day exponential moving average is 2.15, which is a Buy signal.
- The stock price of APVO is 8.70 while Aptevo Therapeutics 20-day EMA is 1.08, which makes it a Buy.
- Aptevo Therapeutics 50-day exponential moving average is 0.61 while APVO share price is 8.70, making it a Buy technically.
- APVO stock price is 8.70 and Aptevo Therapeutics 200-day simple moving average is 5.26, creating a Buy signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $95.13 per share, and an increase next year of $1.74 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
- APVO Moving Average Covergence Divergence (MACD) indicator is 0.68, suggesting Aptevo Therapeutics is a Buy
- Aptevo Therapeutics Relative Strength Index (RSI) is 45.25, which suggest Aptevo Therapeutics is oversold
- The Bollinger Bands (25) for Aptevo Therapeutics is (-1.04 - 2.26), which suggest Aptevo Therapeutics is a Buy
- The Bollinger Bands (100) for Aptevo Therapeutics is (-0.46 - 1.22), which suggest Aptevo Therapeutics is a Buy
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.